MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
10.40
-0.28 (-2.62%)
Oct 13, 2026, 4:00 PM EDT - Market closed
MLTX Market Cap
MLTX has a market cap or net worth of $884.68 million as of October 13, 2026. It is the 10,747th most valuable company in the world and the 2,303rd biggest in the United States. Its market cap has increased by 35.79% in one year.
Market Cap
884.68M
Enterprise Value
449.19M
1-Year Change
35.79%
Global Rank
Country Rank
#2,303 United States
Category
ChartMarket Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $884.68M, an increase of 24,487.68%. That is a compound annual growth rate of 225.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 884.68M | -5.96% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Seaport Therapeutics | 971.58M |
| Alto Neuroscience | 956.33M |
| Kura Oncology | 942.98M |
| Alumis | 926.76M |
| Rigel Pharmaceuticals | 916.81M |
| Jade Biosciences | 915.17M |
| Odyssey Therapeutics | 910.45M |
| Corvus Pharmaceuticals | 884.95M |